Please be informed our LabShop will undergo some upgrading and maintenance work and will not be accessible on April 20, 2025 (Sunday) from 12AM to 4AM. We apologize for any inconvenience caused and appreciate your patient. Thank You
The multiplex digital PCR company, Stilla Technologies makes absolute quantification of multiple genetic markers and multiple tests from a single sample possible for the first time.
About Stilla Technologies
Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, infectious disease detection, and food and environmental testing.
Stilla’s groundbreaking Crystal Digital PCR™ solution, the naica® system, is the industry’s first digital PCR system featuring six fluorescent channels, providing biomedical researchers and clinicians the highest multiplexing and detection capacity available on the market. Stilla has U.S. headquarters in Boston, MA, European headquarters in Paris, France, and strategic distribution and business partnerships in China and throughout EMEA.
